Matches in Wikidata for { <http://www.wikidata.org/entity/Q92109293> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q92109293 description "article scientifique (publié 2020)" @default.
- Q92109293 description "articolo scientifico (pubblicato il 2020)" @default.
- Q92109293 description "artigo científico (publicado na 2020)" @default.
- Q92109293 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q92109293 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92109293 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92109293 description "scientific article published on 01 January 2020" @default.
- Q92109293 description "wetenschappelijk artikel" @default.
- Q92109293 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q92109293 description "научна статия" @default.
- Q92109293 description "գիտական հոդված հրատարակված 2020 թվականի հունվարի 1-ին" @default.
- Q92109293 name "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 name "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 name "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 type Item @default.
- Q92109293 label "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 label "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 label "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 prefLabel "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 prefLabel "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 prefLabel "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 P1433 Q92109293-C87A6247-CAC6-4545-96EF-C88BF7ACFAE0 @default.
- Q92109293 P1476 Q92109293-E7F2ADAA-92BD-4C31-9741-EFCD86E7AAD6 @default.
- Q92109293 P2093 Q92109293-0793EDF1-9410-48C3-A4B0-87361DB73E14 @default.
- Q92109293 P2093 Q92109293-1C176A2E-FA12-42D4-98D5-FAFECAAE77F1 @default.
- Q92109293 P2093 Q92109293-468647D7-60D8-48A5-8B19-7CF03016DFA9 @default.
- Q92109293 P2093 Q92109293-66E21550-7F7D-4EC3-A182-D18C6FBA9A24 @default.
- Q92109293 P2093 Q92109293-89B837D3-6DF2-464C-8F3E-0DE6E681D68C @default.
- Q92109293 P2093 Q92109293-95417DDC-F796-4466-BD90-A137B2D67224 @default.
- Q92109293 P2093 Q92109293-D69C4057-4755-4DB2-A7AB-3B036B874CF3 @default.
- Q92109293 P275 Q92109293-B3D9483D-5F63-40B9-BECC-22CE4922DFAB @default.
- Q92109293 P304 Q92109293-E8DA2473-A4F0-472E-98EF-38733D8216E6 @default.
- Q92109293 P31 Q92109293-5EB900B4-14CB-4262-9A93-ED3BE3B47E91 @default.
- Q92109293 P356 Q92109293-B33C73F3-9D3F-43FF-9682-A4ECD7517D9F @default.
- Q92109293 P478 Q92109293-2B0139B7-7B9D-482D-ADBE-6FFAD8FED7A5 @default.
- Q92109293 P50 Q92109293-7767B1B9-BC7B-4DD8-B7D7-7F2D92A47237 @default.
- Q92109293 P577 Q92109293-1A993125-052A-4AB7-853A-5B906C19DF40 @default.
- Q92109293 P6216 Q92109293-5C09B298-8EE5-4FE4-83DF-7970E83BF1E0 @default.
- Q92109293 P698 Q92109293-AF2FEEAE-1FF0-4FDB-842D-DAF80BAEC299 @default.
- Q92109293 P932 Q92109293-4AD05C76-B5C9-44CB-8023-575100AC8E9D @default.
- Q92109293 P356 0963689720919434 @default.
- Q92109293 P698 32314613 @default.
- Q92109293 P1433 Q15761863 @default.
- Q92109293 P1476 "Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies" @default.
- Q92109293 P2093 "Guoqing Wei" @default.
- Q92109293 P2093 "He Huang" @default.
- Q92109293 P2093 "Houli Zhao" @default.
- Q92109293 P2093 "Luxin Yang" @default.
- Q92109293 P2093 "Mingming Zhang" @default.
- Q92109293 P2093 "Wenjun Wu" @default.
- Q92109293 P2093 "Yongxian Hu" @default.
- Q92109293 P275 Q34179348 @default.
- Q92109293 P304 "963689720919434" @default.
- Q92109293 P31 Q13442814 @default.
- Q92109293 P356 "10.1177/0963689720919434" @default.
- Q92109293 P478 "29" @default.
- Q92109293 P50 Q92109288 @default.
- Q92109293 P577 "2020-01-01T00:00:00Z" @default.
- Q92109293 P6216 Q50423863 @default.
- Q92109293 P698 "32314613" @default.
- Q92109293 P932 "7444226" @default.